Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efraloctocog alfa post-marketing study in Japan
jRCT1080223822Phase 4Completed
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4 trial of efraloctocog alfa in hemophilia A. Started Feb 2018; status: completed.
02
Drugs
efraloctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on jRCT1080223822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223822.